Juniper Pharmaceuticals Company Profile (NASDAQ:JNP)

About Juniper Pharmaceuticals

Juniper Pharmaceuticals logoJuniper Pharmaceuticals, Inc., formerly Columbia Laboratories, Inc., is a women's health therapeutic company focused on developing intra-vaginal therapeutics that addresses the medical needs in women's health. The Company operates through two segments: product and service. The product segment includes supply chain management for CRINONE. The product segment also includes the royalty stream the Company receives from Allergan for CRINONE sales in the United States, as well as the development of new product candidates. The service segment includes pharmaceutical development, clinical trial manufacturing and advanced analytical and consulting services for the its customers, as well as characterizing and developing pharmaceutical product candidates for its internal programs, and managing the preclinical and clinical manufacturing of COL-1077 and its intra-vaginal ring (IVR). Its product and product development programs include CRINONE 8%, COL-1077, JNP-0101, JNP-0101 and JNP-0301.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: JNP
  • CUSIP:
Key Metrics:
  • Previous Close: $5.71
  • 50 Day Moving Average: $7.18
  • 200 Day Moving Average: $7.16
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -142.75
  • P/E Growth: 0.00
  • Market Cap: $61.91M
  • Outstanding Shares: 10,843,000
  • Beta: 0.64
Additional Links:
Companies Related to Juniper Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Juniper Pharmaceuticals (NASDAQ:JNP) (?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $12.42 (117.45% upside)

Analysts' Ratings History for Juniper Pharmaceuticals (NASDAQ:JNP)
Show:
DateFirmActionRatingPrice TargetDetails
8/21/2016Roth CapitalSet Price TargetBuy$16.50View Rating Details
8/19/2016HC WainwrightDowngradeBuy -> Neutral$6.75View Rating Details
8/18/2016Northland SecuritiesDowngradeOutperform -> Market PerformView Rating Details
(Data available from 8/27/2014 forward)

Earnings

Earnings History for Juniper Pharmaceuticals (NASDAQ:JNP)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
8/4/2016Q216($0.08)($0.16)$9.48 millionViewN/AView Earnings Details
5/4/2016Q116($0.08)$0.03$9.13 million$12.10 millionViewN/AView Earnings Details
3/10/2016Q415($0.02)($0.19)$7.89 million$7.60 millionViewN/AView Earnings Details
11/10/2015Q315($0.05)$0.09$7.10 million$11.50 millionViewN/AView Earnings Details
8/4/2015Q215($0.02)($0.03)$8.35 million$10.20 millionViewN/AView Earnings Details
5/6/2015Q115$0.04$0.07$7.80 million$8.30 millionViewN/AView Earnings Details
3/18/2015Q414$0.07($0.05)$7.93 million$7.30 millionViewN/AView Earnings Details
10/28/2014Q314$0.12$0.34$9.74 million$11.50 millionViewN/AView Earnings Details
7/31/2014Q2$0.11$0.01ViewN/AView Earnings Details
4/29/2014Q114$0.07$0.01$6.30 million$7.20 millionViewN/AView Earnings Details
3/5/2014Q413$0.08$7.10 million$7.80 millionViewN/AView Earnings Details
11/7/2013Q313$0.16$0.20$6.75 million$7.10 millionViewN/AView Earnings Details
8/7/2013Q2 2013$0.02$0.03$6.50 million$7.02 millionViewN/AView Earnings Details
5/9/2013Q1 2013$0.03$0.01$6.50 million$6.30 millionViewN/AView Earnings Details
3/14/2013Q4 2012$0.02$0.03$7.60 million$6.10 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Juniper Pharmaceuticals (NASDAQ:JNP)
Current Year EPS Consensus Estimate: $-0.41 EPS
Next Year EPS Consensus Estimate: $-0.04 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161$0.11$0.11$0.11
Q2 20161$0.10$0.10$0.10
Q3 20161$0.12$0.12$0.12
Q4 20161$0.08$0.08$0.08
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Juniper Pharmaceuticals (NASDAQ:JNP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Juniper Pharmaceuticals (NASDAQ:JNP)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/23/2016James A GeraghtyDirectorBuy7,000$5.96$41,720.00View SEC Filing  
12/4/2015C Ann MerrifieldDirectorBuy1,600$12.14$19,424.00View SEC Filing  
11/19/2015Nikin PatelCOOBuy5,000$11.82$59,100.00View SEC Filing  
11/18/2015Frank Condella JrCEOBuy5,000$11.68$58,400.00View SEC Filing  
8/14/2015C Ann MerrifieldDirectorBuy3,000$9.90$29,700.00View SEC Filing  
6/15/2015Frank M ArmstrongDirectorBuy1,255$7.95$9,977.25View SEC Filing  
6/9/2015Nikin PatelCOOBuy13,500$7.52$101,520.00View SEC Filing  
5/8/2015Frank Condella JrCEOBuy10,000$7.36$73,600.00View SEC Filing  
11/20/2014Donald H HunterDirectorBuy1,000$5.98$5,980.00View SEC Filing  
8/13/2014Frank Condella JrCEOBuy10,000$5.98$59,800.00View SEC Filing  
5/5/2014Frank Condella JrCEOBuy10,000$6.65$66,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Juniper Pharmaceuticals (NASDAQ:JNP)
DateHeadline
4-traders.com logoJuniper Pharmaceuticals : Reports Results from Phase 2b Clinical Trial of COL-1077 Lidocaine Vaginal Gel in Gynecologic Procedure Pain (NASDAQ:JNP)
www.4-traders.com - August 25 at 5:48 PM
capitalcube.com logoETF’s with exposure to Juniper Pharmaceuticals, Inc. : August 22, 2016 (NASDAQ:JNP)
www.capitalcube.com - August 22 at 5:48 PM
News IconJuniper Pharmaceuticals Reports Results from Phase 2b Clinical Trial of COL-1077 Lidocaine Vaginal Gel in Gynecologic Procedu... (NASDAQ:JNP)
ih.advfn.com - August 19 at 5:46 PM
streetinsider.com logoJuniper Pharma (JNP) to Discontinue Development of COL-1077 After Phase 2b Trial Fails (NASDAQ:JNP)
www.streetinsider.com - August 18 at 5:48 PM
fidaily.com logoNorthland Securities Cuts Rating On Juniper Pharmaceuticals, Inc. (JNP) To “Market Perform” (NASDAQ:JNP)
www.fidaily.com - August 18 at 5:48 PM
biz.yahoo.com logoJUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:JNP)
biz.yahoo.com - August 18 at 8:50 AM
publicnow.com logoJuniper Pharmaceuticals Reports Results from Phase 2b Clinical Trial of COL-1077 Lidocaine Vaginal Gel in Gynecologic Procedure Pain (NASDAQ:JNP)
www.publicnow.com - August 17 at 5:59 PM
finance.yahoo.com logoJUNIPER PHARMACEUTICALS INC Financials (NASDAQ:JNP)
finance.yahoo.com - August 13 at 5:36 PM
capitalcube.com logoETF’s with exposure to Juniper Pharmaceuticals, Inc. : August 11, 2016 (NASDAQ:JNP)
www.capitalcube.com - August 11 at 6:01 PM
capitalcube.com logoJuniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:JNP)
www.capitalcube.com - August 9 at 5:57 PM
sg.finance.yahoo.com logoJuniper Pharmaceuticals posts 2Q loss (NASDAQ:JNP)
sg.finance.yahoo.com - August 4 at 6:03 PM
biz.yahoo.com logoQ2 2016 Juniper Pharmaceuticals Inc Earnings Release - Before Market Open (NASDAQ:JNP)
biz.yahoo.com - August 4 at 8:52 AM
publicnow.com logoJuniper Pharmaceuticals Reports Second Quarter 2016 Financial Results (NASDAQ:JNP)
www.publicnow.com - August 4 at 8:52 AM
biz.yahoo.com logoJUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a (NASDAQ:JNP)
biz.yahoo.com - July 28 at 4:47 PM
publicnow.com logoJuniper Pharmaceuticals to Report Second Quarter 2016 Results on August 4, 2016 (NASDAQ:JNP)
www.publicnow.com - July 26 at 8:18 AM
prnewswire.com logoJuniper Pharmaceuticals Appoints Alicia Secor President and Chief Executive Officer (NASDAQ:JNP)
www.prnewswire.com - July 21 at 11:52 AM
News IconShares Experiencing a Downtrend: Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - TGP (NASDAQ:JNP)
telanaganapress.com - July 16 at 9:08 AM
News IconUnusual Volume on Shares of: Juniper Pharmaceuticals, Inc. (NASDAQ:JNP) - Engelwood Daily (NASDAQ:JNP)
www.engelwooddaily.com - July 9 at 9:09 AM
news.cmlviz.com logoJuniper Pharmaceuticals Inc. Realized Volatility Hits Elevated Level - CML News (NASDAQ:JNP)
news.cmlviz.com - July 9 at 9:09 AM
finance.yahoo.com logoJuniper Pharmaceuticals Announces Completion of Enrollment in Phase 2b Clinical Trial of COL-1077 10% Lidocaine ... - Yahoo Finance (NASDAQ:JNP)
finance.yahoo.com - July 8 at 8:40 AM
News IconHit List News Buzzer - Juniper Pharmaceuticals (NASDAQ:JNP), Transocean (NYSE:RIG), SUPERVALU (NYSE:SVU) - Seneca Globe (NASDAQ:JNP)
www.senecaglobe.com - July 8 at 8:40 AM
News IconJuniper Pharmaceuticals Inc on Focus After Raising In Today's Session - Press Telegraph (NASDAQ:JNP)
presstelegraph.com - July 8 at 8:40 AM
publicnow.com logoJuniper Pharmaceuticals Announces Completion of Enrollment in Phase 2b Clinical Trial of COL-1077 10% Lidocaine Vaginal Gel for Gynecologic Procedure Pain (NASDAQ:JNP)
www.publicnow.com - July 7 at 9:11 AM
finance.yahoo.com logoJuniper Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference (NASDAQ:JNP)
finance.yahoo.com - June 29 at 8:00 AM
streetinsider.com logoJuniper Pharma (JNP) Announces Publication of Data from Two COL-1077 Phase 1s; Plans to Report Topline Data in Q3 (NASDAQ:JNP)
www.streetinsider.com - June 17 at 8:32 AM
finance.yahoo.com logoJuniper Pharmaceuticals Announces Phase 1 Studies of COL-1077 Lidocaine Vaginal Gel Published in Peer Reviewed Scientific Journal (NASDAQ:JNP)
finance.yahoo.com - June 16 at 5:53 PM
biz.yahoo.com logoJUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements a (NASDAQ:JNP)
biz.yahoo.com - June 15 at 5:18 PM
finance.yahoo.com logoCatalyst Pharmaceuticals (CPRX) Jumps: Stock Rises 6.6% (NASDAQ:JNP)
finance.yahoo.com - June 14 at 8:25 AM
zacks.com logoAchaogen (AKAO) Shows Strength: Stock Moves 13% Higher (NASDAQ:JNP)
www.zacks.com - June 3 at 8:30 AM
prnewswire.com logoJuniper Pharmaceuticals Announces Planned Retirement of CEO Frank Condella (NASDAQ:JNP)
www.prnewswire.com - June 2 at 8:36 AM
biz.yahoo.com logoJUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, (NASDAQ:JNP)
biz.yahoo.com - June 2 at 7:06 AM
finance.yahoo.com logoARIAD (ARIA) Commences Phase I/II Study on Cancer Drug (NASDAQ:JNP)
finance.yahoo.com - June 1 at 5:05 PM
News IconPerformance at a Glance on Juniper Pharmaceuticals, Inc. (:JNP) - HNN (NASDAQ:JNP)
hintsnewsnetwork.com - May 29 at 12:30 PM
prnewswire.com logoJuniper Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference - PR Newswire (press release) (NASDAQ:JNP)
www.prnewswire.com - May 26 at 11:53 AM
finance.yahoo.com logoJuniper Pharmaceuticals to Present at Jefferies 2016 Healthcare Conference (NASDAQ:JNP)
finance.yahoo.com - May 24 at 10:15 AM
capitalcube.com logoJuniper Pharmaceuticals, Inc. :JNP-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:JNP)
www.capitalcube.com - May 18 at 1:42 PM
biz.yahoo.com logoQ1 2016 Juniper Pharmaceuticals Inc Earnings Release - Time Not Supplied (NASDAQ:JNP)
biz.yahoo.com - May 4 at 7:07 AM
sg.finance.yahoo.com logoJuniper Pharmaceuticals posts 1Q profit (NASDAQ:JNP)
sg.finance.yahoo.com - May 4 at 6:21 AM
finance.yahoo.com logoJuniper Pharmaceuticals Reports First Quarter 2016 Financial Results (NASDAQ:JNP)
finance.yahoo.com - May 4 at 6:00 AM
finance.yahoo.com logoJuniper Pharmaceuticals to Report First Quarter 2016 Results on May 4, 2016 (NASDAQ:JNP)
finance.yahoo.com - April 26 at 8:00 AM
finance.yahoo.com logoJuniper Pharmaceuticals Appoints Dr. Herman Weiss as Vice President, Medical Affairs and Clinical Development (NASDAQ:JNP)
finance.yahoo.com - March 30 at 8:00 AM
bizjournals.com logoJuniper's board has greater ratio of women than any other firm in Mass. (NASDAQ:JNP)
www.bizjournals.com - March 28 at 11:30 AM
marketexclusive.com logoJuniper Pharmaceuticals Inc (NASDAQ:JNP) 4Q Loss Widens - Market Exclusive (NASDAQ:JNP)
marketexclusive.com - March 11 at 3:02 PM
marketexclusive.com logoJuniper Pharmaceuticals Inc (NASDAQ:JNP) 4Q Loss Widens (NASDAQ:JNP)
marketexclusive.com - March 11 at 3:02 PM
sg.finance.yahoo.com logoJuniper Pharmaceuticals posts 4Q loss (NASDAQ:JNP)
sg.finance.yahoo.com - March 10 at 10:00 AM
biz.yahoo.com logoQ4 2015 Juniper Pharmaceuticals Inc Earnings Release - Time Not Supplied (NASDAQ:JNP)
biz.yahoo.com - March 10 at 7:07 AM
biz.yahoo.com logoJUNIPER PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a (NASDAQ:JNP)
biz.yahoo.com - March 10 at 6:26 AM
finance.yahoo.com logo6:22 am Juniper Pharma reports Q4 results (NASDAQ:JNP)
finance.yahoo.com - March 10 at 6:22 AM
finance.yahoo.com logoJuniper Pharmaceuticals Reports Fourth Quarter and Full-Year 2015 Financial Results (NASDAQ:JNP)
finance.yahoo.com - March 10 at 6:17 AM
seekingalpha.com logoHealthcare ratings roundup - new coverage #1 - Seeking Alpha (NASDAQ:JNP)
seekingalpha.com - March 5 at 2:28 PM

Social

Juniper Pharmaceuticals (NASDAQ:JNP) Chart for Saturday, August, 27, 2016


Last Updated on 8/27/2016 by MarketBeat.com Staff